This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: **Joerg Moeller: Innovator in Protein Production**
Introduction
Joerg Moeller, an accomplished inventor based in Bad Soden, Germany, has made significant contributions to the field of biotechnology. His innovative approach focuses on the production of heterologous proteins, demonstrating his expertise and vision in addressing biological challenges.
Latest Patents
Moeller holds a patent for a groundbreaking process that utilizes the yeast ADH II promoter system for the production of heterologous proteins in high yields. This invention has important applications in the preparation of substances such as hirudins, miniproinsulins, and leptins, among others. The patent underscores Moeller's commitment to advancing biotechnological methods that can lead to better therapeutic results.
Career Highlights
Throughout his career, Joerg Moeller has been closely associated with Hoechst Aktiengesellschaft, where he has applied his knowledge and skills to improve biotechnological processes. His dedication to innovation has played a vital role in the company's research and development efforts, further establishing him as a respected figure in the field.
Collaborations
Moeller has collaborated with notable colleagues such as Werner Badziong and Paul Habermann. These partnerships reflect a shared commitment to scientific advancement, and together they have contributed to the development of innovative processes and technologies in the biotechnology sector.
Conclusion
In summary, Joerg Moeller exemplifies the spirit of innovation within the realm of biotechnological research. His patent and collaborations highlight his significant impact on the production of critical proteins, aligning with the ongoing pursuit of advancements in the life sciences. As he continues his work, Moeller remains a key player in shaping the future of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
